Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl TAIFUN for breakthrough cancer pain in opioid-tolerant patients
2007-005382-35Phase 3Completed
- Sponsor
- Akela Pharma Inc.
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fentanyl in breakthrough pain (2 arms), sponsored by Akela Pharma Inc. Started May 2008; status: completed.
02
Drugs
fentanyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on 2007-005382-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005382-35.